(0.16%) 5 469.00 points
(0.19%) 39 192 points
(0.54%) 17 828 points
(1.86%) $83.06
(-3.81%) $2.50
(-0.08%) $2 337.70
(0.12%) $29.60
(-1.29%) $989.00
(-0.15%) $0.932
(-0.13%) $10.66
(0.00%) $0.791
(1.05%) $86.62
Q1/2024
Generated By Getagraph.com: 2024-04-30
Streamline Health [STRM]
7.42% $ 0.495
Биржа: NASDAQ Сектор: Healthcare Промышленность: Health Information Services
The earnings call was led by Jacob Goldberger, Vice President of Finance, accompanied by Ben Stilwill, President and Chief Executive Officer, and BJ Reeves, Chief Financial Officer. During the call, management discussed the significant progress made during the first quarter of fiscal 2024, enhancing the value provided to the healthcare revenue cycle through product improvements and new client acquisitions. They expressed confidence in achieving an adjusted EBITDA breakeven run rate in the second half of the fiscal year due to improved operational efficiency, product functionality, and additional client partnerships.
Streamline Health Solutions Inc. reported a total revenue of $4.3M for the first quarter of fiscal 2024, compared to $5.3M in the same period of fiscal 2023. This change was primarily due to previously announced client non-renewals, offset by successful new SaaS contracts. Pro forma SaaS revenue grew 22% after excluding revenues from the non-renewal client, indicating robust underlying growth in the company’s core SaaS business.
The company’s operating expenses decreased to $6.6M from $8.3M in the first quarter of the previous fiscal year. This reduction resulted from a strategic restructuring that reduced SG&A and R&D costs, professional fees, and software license costs.
Despite the lower revenue, the company’s net loss declined slightly to $2.7M from $2.9M in the first quarter of fiscal 2023, thanks to cost-saving measures. Adjusted EBITDA showed a significant improvement with a loss of $0.7M compared to a loss of $1.3M in the previous year's first quarter.
As of April 30, 2024, Streamline Health Solutions had $4M in cash, up from $3.2M as of January 31, 2024. Total debt stood at $12.5M, with no balance on the company’s revolving credit facility.
The company's total assets were $41.7M with $24.42M in total liabilities, translating to a total stockholders' equity of $17.3M. Notable line items included $3.98M in cash and short-term investments, $4.71M in net receivables, and $24.94M in goodwill and intangible assets.
For the first quarter of fiscal 2024, the company reported a net cash change of $789K, resulting in an ending cash balance of $3.98M. Despite a net income loss of $2.7M, strategic investments and financing activities, including a private placement grossing $4.5M, contributed positively to cash flow.
Streamline Health Solutions continues to innovate in AI and automation, enhancing product functionality and client services. The AI model for revenue cycle management has already shown significant impact, enhancing coding accuracy and financial outcomes for clients. The company also emphasized its strategic partnerships, particularly with Oracle, which have shown positive traction in driving new client acquisitions and revenue growth.
Management highlighted successful client implementations that provided substantial financial impacts. One example included a 700-bed hospital seeing $1M of impact in one quarter.
The company’s Altman Z Score of -3.40 indicates a level of financial distress when compared to its peers. The current market cap is $31.99M with a total working capital of -$3.11M.
Streamline Health Solutions exhibited lower operating and net profit margins compared to industry standards, with metrics like gross profit margin at 51.22%, operating profit margin at -87.48%, and net profit margin at -85.83%. The company’s return on equity stood at -85.25%, contrasting sharply with a peer average of 5.56%.
In liquidity analysis, the current ratio was 0.75, and the quick ratio was 0.70, both lower than the industry averages, suggesting potential liquidity challenges. The company's debt-equity ratio was 51.08%, indicative of a moderate leverage position compared to peers.
Looking ahead, Streamline Health Solutions Inc. plans to drive revenue growth through continued client acquisition and product innovation, leveraging AI and automation in its service offerings. Management anticipates revenue growth on relatively static expenses and aims to achieve persistent positive adjusted EBITDA in the second half of fiscal 2024.
For additional information, you can review the complete earnings announcement on the company’s website or through the SEC’s official filing.
Revenues Q1 - 2024
Revenue | Gross Profit | Operating Expenses | Interest Expense | EBITDA | Net Income | EPS |
---|---|---|---|---|---|---|
$4.33M | $2.24M | $3.73M | $465 000 | $-371 000 | $-2.74M | $-0.0470 |
Balance Q1 - 2024
Net Income | Depreciation and Amortization | Stock Based Compensation | Change in Working Capital | Net Cash Provided by Operating Activities | Capital Expenditure | Free Cash Flow |
---|---|---|---|---|---|---|
$-2.74M | $1.12M | $499 000 | $-255 000 | $-1.20M | $-232 000 | $-1.43M |